Naloxone
Naloxone is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Naloxone Hydrochloride. Available dosage forms: powder, spray.
Drug Details
- Generic Name
- Naloxone
- Brand Names
- Naloxone Hydrochloride
- Application Number
- ANDA217992
- Sponsor
- Pharmaron Manufacturing Services (UK) Ltd
- NDC Codes
- 2
- Dosage Forms
- POWDER, SPRAY
- Routes
- NASAL
- Active Ingredients
- NALOXONE HYDROCHLORIDE DIHYDRATE, NALOXONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )